SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-18-001580
Filing Date
2018-06-01
Accepted
2018-06-01 20:30:54
Documents
1
Period of Report
2018-05-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT mclaughlin_frm4.html 4  
1 OWNERSHIP DOCUMENT mclaughlin_frm4.xml 4 3303
  Complete submission text file 0001683168-18-001580.txt   4784
Mailing Address OCULUS INNOVATIVE SCIENCES, INC. 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address
MCLAUGHLIN JOHN (Reporting) CIK: 0001203240 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33216 | Film No.: 18876683

Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations